Rockville, MD, United States of America

Richard T Sawyer



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard T Sawyer: Innovator in Thiol-Containing Compound Therapy

Introduction

Richard T Sawyer is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of conditions related to thiol-containing compounds. His innovative approach has the potential to impact the lives of many patients suffering from cystic fibrosis and similar conditions.

Latest Patents

Richard T Sawyer holds a patent for "Methods for treatment of thiol-containing compound deficient conditions." This patent outlines methods for therapy of cystic fibrosis and other related conditions. The methods involve the use of agents capable of increasing thiol-containing compound transport via a transporter system, such as ABC transporters like MDR-1 or MRP-2, in cells. Additionally, the patent includes embodiments that utilize agents to modulate the transport of thiol-containing compounds within the cell. Therapeutic methods described in the patent involve administering these agents to patients afflicted with cystic fibrosis or other conditions responsive to stimulation of thiol-containing compound transport. He has 1 patent to his name.

Career Highlights

Throughout his career, Richard T Sawyer has worked with esteemed organizations such as the National Jewish Medical and Research Center and National Jewish Health. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Richard has collaborated with notable colleagues, including Brian J Day and Lee S Newman. These partnerships have further enriched his research and development efforts in the medical field.

Conclusion

Richard T Sawyer's innovative work in the treatment of thiol-containing compound deficiencies showcases his dedication to improving patient outcomes. His contributions to medical therapy continue to pave the way for advancements in the treatment of cystic fibrosis and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…